Press release
Peanut Allergy Market is projected to reach USD 4.08 billion by 2034
Peanut Allergy
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71354
Peanut allergy is one of the most common and severe food allergies, particularly in children, and is associated with life-threatening anaphylaxis. Traditional management has relied on strict avoidance and emergency epinephrine use. However, the market is undergoing a major shift with the commercialization of oral immunotherapy (OIT), development of epicutaneous immunotherapy (EPIT) patches, sublingual immunotherapy (SLIT), and advanced biologics targeting IgE-mediated hypersensitivity.
Key Market Highlights
• 2024 Market Size: USD 1.32 billion
• 2034 Forecast: USD 4.08 billion
• CAGR (2025-2034): 11.9%
• Largest Segment: Oral Immunotherapy (OIT)
• Fastest-Growing Segment: Biologic therapies
Epidemiology & Clinical Insights
1. Prevalence
• Peanut allergy affects ~1-2% of children in many Western countries.
• Prevalence increasing globally due to changing dietary patterns and early-life sensitization.
• Approximately 20% of children may outgrow the condition, but the majority remain allergic into adulthood.
2. Clinical Severity
Symptoms range from:
• Urticaria
• Angioedema
• Gastrointestinal distress
• Respiratory compromise
• Anaphylaxis (life-threatening)
3. Diagnosis
• Skin prick testing
• Peanut-specific IgE measurement
• Component-resolved diagnostics (Ara h2)
• Oral food challenge (gold standard)
Market Growth Drivers
1. Approval & Uptake of Oral Immunotherapy (OIT)
First-in-class therapies have provided the option of controlled desensitization, reducing risk of severe reactions.
2. Rapid R&D Growth in Allergy Immunotherapy
Pipeline includes OIT, EPIT patches, SLIT drops, DNA vaccines, and tolerance-inducing biologics.
3. Rising Incidence of Food Allergies in Children
Urbanization, altered microbiome exposure, and genetic predisposition drive prevalence.
4. High Unmet Need for Safe, Long-Term Desensitization
Families seek therapies that provide real-world protection against accidental exposure.
5. Increased Epinephrine Auto-Injector Use
Supports emergency preparedness for moderate-to-severe peanut allergy.
Market Restraints
• Risk of adverse reactions during OIT
• Need for long-term adherence to maintenance dosing
• High treatment cost for innovative therapies
• Limited data on lifelong immune tolerance after therapy
• Anxiety and compliance challenges in pediatric patient populations
Market Opportunities
1. Epicutaneous Immunotherapy (EPIT) Patches
Non-invasive, safer options for young children under development.
2. Biologic Therapies Targeting IgE Pathways
Monoclonal antibodies (e.g., anti-IgE) show strong potential in combination with OIT.
3. Microbiome-Based & DNA Vaccines
Emerging approaches to reprogram immune tolerance.
4. AI-Based Prediction of Anaphylaxis Risk
Personalized treatment plans based on immune profiling.
5. Expansion of Early Allergen Introduction Programs
Supports preventive strategies and early sensitization management.
Segmentation Overview
By Treatment Type
• Oral Immunotherapy (OIT)
• Epicutaneous Immunotherapy (EPIT)
• Sublingual Immunotherapy (SLIT)
• Biologic therapies
• Emergency epinephrine
• Supportive & avoidance-based management
By Age Group
• Pediatric (4-17 years)
• Adult
By Route of Administration
• Oral
• Transdermal
• Sublingual
• Injectable
By End User
• Allergy clinics
• Hospitals
• Ambulatory care centers
• Home-based therapy (post-initiation)
Explore Full Report here: https://exactitudeconsultancy.com/reports/71354/peanut-allergy-market
Regional Insights
North America - Largest Market
High food allergy prevalence, strong regulatory approvals for OIT, and robust research ecosystem.
Europe - Strong Growth in Immunotherapy Adoption
EPIT and SLIT clinical development accelerating in EU countries.
Asia Pacific - Fastest Growing
Rising awareness, urbanization-associated allergy prevalence, and expanding pediatric allergy care.
Latin America - Increasing Diagnosis Rates
Improved clinical access and emergency care.
Middle East & Africa - Emerging Adoption
Growing burden of pediatric food allergies and improved allergology services.
Competitive Landscape
Key players shaping the Peanut Allergy Market include:
• Aimmune Therapeutics (Nestlé Health Science)
• DBV Technologies
• AllerGenis
• Regeneron Pharmaceuticals
• Sanofi
• Novartis
• Genentech
• Aravax
• Prota Therapeutics
• ALK-Abelló
Focus areas: OIT commercialization, EPIT patch development, IgE-targeting biologics, and immune tolerance therapies.
Recent Market Developments
• Expanded commercialization efforts for FDA-approved OIT products
• Phase III advancements of EPIT patches for young children
• Increasing use of anti-IgE biologics alongside desensitization
• Growth in real-world data supporting long-term effectiveness of OIT
• AI-driven food allergy diagnostic tools becoming mainstream
Future Outlook (2025-2034)
The Peanut Allergy Market is expected to grow rapidly as:
• First- and second-generation OIT therapies expand globally
• EPIT patches reach regulatory approval for younger age groups
• Biologic therapies redefine severe allergy management
• Digital monitoring tools improve adherence and safety
• Predictive immunology supports personalized dosing strategies
By 2034, the market is forecasted to reach USD 4.08 billion, reflecting sustained demand for desensitization therapies and rising global allergy burden.
This report is also available in the following languages : Japanese (ピーナッツアレルギー市場), Korean (땅콩 알레르기 시장), Chinese (花生过敏市场), French (Marché des allergies aux arachides), German (Erdnussallergie-Markt), and Italian (Mercato delle allergie alle arachidi), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/request-sample/71354
Our More Reports:
Drug Eruptions Market
https://exactitudeconsultancy.com/reports/71408/drug-eruptions-market
Allergic Asthma due to Dermatophagoides Farinae Market
https://exactitudeconsultancy.com/reports/71484/allergic-asthma-due-to-dermatophagoides-farinae-market
DNA Vaccine Market
https://exactitudeconsultancy.com/reports/72393/dna-vaccine-market
Nasal Drug Delivery Market
https://exactitudeconsultancy.com/reports/72644/nasal-drug-delivery-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peanut Allergy Market is projected to reach USD 4.08 billion by 2034 here
News-ID: 4310116 • Views: …
More Releases from Exactitude Consultancy
Cytomegalovirus (CMV) Infections Market is projected to reach USD 3.12 billion b …
The global Cytomegalovirus (CMV) Infections Market was valued at USD 1.76 billion in 2024 and is projected to reach USD 3.12 billion by 2034, growing at a CAGR of 5.9% during 2025-2034. Rising rates of solid organ and stem cell transplantation, increasing awareness and screening for congenital CMV, and the growing need for effective antiviral therapies are the primary drivers of market expansion.
Download Full PDF Sample Copy of Market Report…
Sarcoidosis Market is Projected to reach USD 3.2-3.7 billion by 2032, reflecting …
Market Overview
The Sarcoidosis market is growing steadily as awareness increases about this systemic inflammatory disease characterized by granuloma formation across organs such as the lungs, skin, lymph nodes, and eyes. Although many cases are mild, a significant portion requires long-term treatment due to organ involvement, especially pulmonary sarcoidosis. Rising diagnostic capabilities, improved imaging technologies, and expanding adoption of immunomodulatory therapies are fueling market growth.
The global Sarcoidosis market was valued at…
Anti-Glomerular Basement Membrane (Anti-GBM) Disease Market is projected to reac …
The global Anti-Glomerular Basement Membrane (Anti-GBM) Disease Market was valued at USD 612 million in 2024 and is projected to reach USD 1.09 billion by 2034, growing at a CAGR of 5.9% from 2025 to 2034. Market expansion is driven by improved diagnostic capabilities, early recognition of autoimmune renal diseases, increasing use of plasmapheresis and immunosuppressive therapies, and growing adoption of advanced biologics for refractory cases.
Download Full PDF Sample Copy…
Pyoderma Gangrenosum (PG) Market the market is expected to reach USD 550-650 mil …
Market Overview
The Pyoderma Gangrenosum (PG) market is expanding gradually as awareness increases about this rare, painful, and rapidly progressive neutrophilic dermatosis. PG commonly presents as ulcerative lesions that require prompt diagnosis and immunosuppressive therapy. Because of its rarity and frequent misdiagnosis, the market is driven largely by advancements in biologics, improved dermatology access, and rising clinical recognition.
The global PG market was valued at USD 350-400 million in 2024. With increasing…
More Releases for OIT
Peanut Allergy Market Detailed Industry Report Analysis 2025-2034
Introduction
Peanut allergy is one of the most common and potentially life-threatening food allergies, especially in children. It is characterized by an abnormal immune response to peanut proteins, which can trigger mild symptoms such as hives and digestive distress or severe, life-threatening anaphylaxis. Unlike other childhood food allergies, peanut allergy often persists into adulthood, creating a lifelong burden for patients and caregivers.
For decades, management focused exclusively on strict peanut avoidance and…
Food Allergy Market Size And Global Industry Forecast 2034
Introduction
Food allergies are immune system reactions that occur when the body mistakenly identifies certain foods as harmful, triggering symptoms ranging from mild hives to severe anaphylactic reactions. The most common food allergens include peanuts, tree nuts, milk, eggs, wheat, soy, fish, and shellfish. The prevalence of food allergies has been steadily increasing, with studies showing that food allergies affect approximately 6-8% of children and 4% of adults globally. The impact…
Octylisothiazolinone (OIT) Market Share| Growth| Trends and Forecast to (2028)|
Los Angeles, United States December 2022,- The research study presented here is a brilliant compilation of different types of analysis of critical aspects of the global Octylisothiazolinone (OIT) market. It sheds light on how the global Octylisothiazolinone (OIT) market is expected to grow during the course of the forecast period. With SWOT analysis and Porter's Five Forces analysis, it gives a deep explanation of the strengths and weaknesses of the global…
Global Octylisothiazolinone (OIT) Market Huge Growth Opportunity between 2020-20 …
LP INFORMATION recently released a research report on the Octylisothiazolinone (OIT) market analysis, which studies the Octylisothiazolinone (OIT)'s industry coverage, current market competitive status, and market outlook and forecast by 2025.
Global "Octylisothiazolinone (OIT) Market 2020-2025" Research Report categorizes the global Octylisothiazolinone (OIT) market by key players, product type, applications and regions,etc. The report also covers the latest industry data, key players analysis, market share, growth…
Unitrin, OIT, ibml, TAWPI Lead Panel Discussion at IASA
News
Optical Image Technology’s (OIT) Jim Thumma will join representatives from Unitrin Direct® Auto and Home Insurance, ibml, and The Association for Work Process Improvement (TAWPI) for a panel presentation entitled Improving ROI by Thinking Outside the Box: Unconventional Uses for a Conventional ECM System at IASA 2010. The session takes place on Tuesday, June 8 at 9:15 a.m. during the June 6-9 conference in Grapevine, Texas.
The panelists will examine the…
OIT Receives 2010 Tech Decisions and Novarica RAVE Award
News
Optical Image Technology (OIT), makers of the DocFinity® suite of document management, imaging, and BPM/workflow software, received the 2010 RAVE Award in the document management category during the ACORD LOMA Insurance Systems Forum in Las Vegas, Nevada, on May 24. The award, which was presented by Tech Decisions for Insurance and Novarica, recognizes solution providers whose technology delivers exemplary value to customers, as measured by senior executives from surveyed customers.
The…
